Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02819141 · ClinicalTrials.gov registry record · Phase 2
Self-management of Sedative Therapy by Ventilated Patients
A Phase 2 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 161
- Enrollment target
NCT02819141: Completed Phase 2 study, sponsored by Mayo Clinic.
NCT02819141 is a Phase 2 study that has completed, run by Mayo Clinic. The registered enrollment target is 161 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02819141, a Phase 2 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 161 participants
- Enrollment target
Study Summary
The purpose of this randomized clinical trial is to test the efficacy of dexmedetomidine for the self-management of sedative therapy (SMST) in a sample of critically ill patients receiving mechanical ventilator support. The investigators hypothesis is that self-management of sedative therapy by mechanically ventilated patients in the intensive care unit (ICU), tailored to their individual needs will be more efficacious than nurse-administered sedative therapy in reducing anxiety, which may reduce duration of mechanical ventilator support and occurrence of delirium.
Interventions
- DRUG Dexmedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2016-11 |
| Est. Completion | 2024-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02819141
The ClinicalTrials.gov registry entry for NCT02819141 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 161 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexmedetomidine is the first listed.
NCT02819141 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02819141 about?
NCT02819141 is a clinical study titled "Self-management of Sedative Therapy by Ventilated Patients". The purpose of this randomized clinical trial is to test the efficacy of dexmedetomidine for the self-management of sedative therapy (SMST) in a sample of critically ill patients receiving mechanical ventilator support. The investigators hypothesis is that self-management of sedative therapy by mech...
What is the current status of trial NCT02819141?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 161 participants. The study started on 2016-11. Estimated completion is 2024-12.
What interventions are being tested in trial NCT02819141?
The interventions under investigation include: Dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT02819141?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.